Emergent BioSolutions secures $60M contracts
2026-03-25 16:21:01 ET
More on Emergent Biosolutions
- Emergent BioSolutions Earnings: Revenue, Margins, And GAAP Losses Paint A Mixed Picture
- Emergent BioSolutions plummets on weak 2026 revenue guidance, Q4 results
- Emergent BioSolutions outlines $720M–$760M 2026 revenue target as transformation plan advances
Read the full article on Seeking Alpha
For further details see:
Emergent BioSolutions secures $60M contractsNASDAQ: ASPR
ASPR Trading
0.0% G/L:
$0.0006 Last:
40,000 Volume:
$0.0006 Open:
ASPR Latest News


